Skip to main content
Clinical Trials/NCT05923138
NCT05923138
Recruiting
Not Applicable

aBOrdaje nutriCional en ADultos Seguidos en hOspitales eSpañoles Por Insuficiencia Cardiaca (BOCADOS-IC)

Spanish Society of Cardiology1 site in 1 country264 target enrollmentNovember 2, 2023
ConditionsHeart Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Spanish Society of Cardiology
Enrollment
264
Locations
1
Primary Endpoint
COMBINED EVENT
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This is a randomized, controlled, open-label, prospective, multicentre clinical trial designed to assess the effects of a nutritional intervention on morbidity and mortality in patients with chronic heart failure.

Through a simple 1:1 randomization process, patients will be assigned to the control group or the intervention group. Patients in the intervention group will undergo an individualised nutritional intervention program consisting of 3 pillars: diet optimization, specific recommendations ,and nutritional supplementation if nutritional targets are not achieved.

Registry
clinicaltrials.gov
Start Date
November 2, 2023
End Date
December 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Spanish Society of Cardiology
Responsible Party
Principal Investigator
Principal Investigator

JOSE ANGEL PEREZ RIVERA

Principal Investigator

Spanish Society of Cardiology

Eligibility Criteria

Inclusion Criteria

  • Patients older than 65 years with malnutrition (MNA-SF score ≤ 11) with chronic ambulatory heart failure (HF).

Exclusion Criteria

  • Admission for heart failure (HF) in the last month,
  • Chronic renal failure on dialysis.
  • Patients already on nutritional treatment.
  • Concomitant diseases which, apart from the HF itself, could lead to a life expectancy of less than 1 year,
  • Patients included in other clinical trials.
  • Patients whose clinical situation makes it impossible to perform a nutritional assessment according to the design established in the study protocol or who do not give their consent for this purpose.
  • Patients who during admission undergo surgical or percutaneous treatment to correct the cause of acute HF,

Outcomes

Primary Outcomes

COMBINED EVENT

Time Frame: 6 MONTHS

Time to the combined event of all-cause mortality or admission for heart failure at 6 months

Secondary Outcomes

  • Changes in nutritional status at 3 and 6 months post intervention(6 MONTHS)
  • Time to all-cause admission at 6 months(6 MONTHS)
  • Time to 6-month cardiovascular mortality(6 MONTHS)
  • Changes in quality of life at 3 and 6 months post-intervention(6 MONTHS)

Study Sites (1)

Loading locations...

Similar Trials